Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Hisse Senetlerindeki Sıralama #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Hisse Fiyatı
$50.93
Piyasa Değeri
$226.32B
Değişim (1 gün)
2.54%
Değişim (1 yıl)
-26.19%
Ülke
DK
Ticaret Novo Nordisk A/S (NVO)

Kategori

Novo Nordisk A/S (NVO) için temettü verimi geçmişi
Novo Nordisk A/S (hisse sembolü: NVO) temettü verimi (TTM) 2024-12-31 itibariyle: 1.59%
Son 5 yılın ortalama temettü verimi: 1.73%
Novo Nordisk A/S (NVO) için 2000 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
2026 (TTM) 3.66% 2.23%
2025 3.58% 125.16%
2024 1.59% 55.88%
2023 1.02% -14.29%
2022 1.19% -6.30%
2021 1.27% -37.13%
2020 2.02% -4.27%
2019 2.11% -18.53%
2018 2.59% 13.60%
2017 2.28% -38.38%
2016 3.70% 193.65%
2015 1.26% -27.59%
2014 1.74% -4.40%
2013 1.82% 20.53%
2012 1.51% -1.31%
2011 1.53% 27.50%
2010 1.20% -33.70%
2009 1.81% 8.38%
2008 1.67% 54.63%
2007 1.08% -14.96%
2006 1.27% -6.62%
2005 1.36% -8.11%
2004 1.48% -2.63%
2003 1.52% -7.32%
2002 1.64% 112.99%
2001 0.77% 8.45%
2000 0.71% 0.00%
Benzer şirketler veya rakiplerin temettü verimi (TTM)